HeartSciences Inc. (HSCS) Cash from Financing Activities (2022 - 2026)

HeartSciences (HSCS) has reported Cash from Financing Activities for 5 consecutive years, with -$63673.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Cash from Financing Activities fell 163.66% year-over-year to -$63673.0; the trailing twelve-month figure through Apr 2026 stood at $5.2 million (up 89.99% YoY), and the FY2026 full-year result was $8.0 million, up 193.74% from the prior year.
• Cash from Financing Activities eased to -$63673.0 in Q2 2026 per HSCS's latest filing, from $1.5 million in the prior quarter.
• Across five years, Cash from Financing Activities topped out at $9.1 million in Q1 2024 and bottomed at -$121522.0 in Q1 2023.
• Historically, Cash from Financing Activities has averaged $1.6 million across 5 years, with a median of $551683.0 in 2024.
• The sharpest annual moves came in 2024 and 2026: Cash from Financing Activities surged 7610.17% in 2024, then tumbled 163.66% in 2026.
• Over 5 years, Cash from Financing Activities stood at -$116392.0 in 2022, then jumped by 542.15% to $514629.0 in 2023, then jumped by 269.53% to $1.9 million in 2024, then decreased by 20.66% to $1.5 million in 2025, then sank by 104.22% to -$63673.0 in 2026.
• According to Business Quant data, Cash from Financing Activities over the past three periods registered -$63673.0, $1.5 million, and $3.6 million for Q2 2026, Q4 2025, and Q3 2025 respectively.